Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

926 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical determinants of quality of life in Paget's disease of bone.
Langston AL, Campbell MK, Fraser WD, Maclennan G, Selby P, Ralston SH. Langston AL, et al. Among authors: selby p. Calcif Tissue Int. 2007 Jan;80(1):1-9. doi: 10.1007/s00223-006-0184-2. Epub 2007 Jan 4. Calcif Tissue Int. 2007. PMID: 17205328
Long-term follow-up for mortality and cancer in a randomized placebo-controlled trial of vitamin D(3) and/or calcium (RECORD trial).
Avenell A, MacLennan GS, Jenkinson DJ, McPherson GC, McDonald AM, Pant PR, Grant AM, Campbell MK, Anderson FH, Cooper C, Francis RM, Gillespie WJ, Robinson CM, Torgerson DJ, Wallace WA; RECORD Trial Group. Avenell A, et al. J Clin Endocrinol Metab. 2012 Feb;97(2):614-22. doi: 10.1210/jc.2011-1309. Epub 2011 Nov 23. J Clin Endocrinol Metab. 2012. PMID: 22112804 Clinical Trial.
Single infusion of zoledronate in Paget's disease of bone: a placebo-controlled, dose-ranging study.
Buckler H, Fraser W, Hosking D, Ryan W, Maricic MJ, Singer F, Davie M, Fogelman I, Birbara CA, Moses AM, Lyles K, Selby P, Richardson P, Seaman J, Zelenakas K, Siris E. Buckler H, et al. Among authors: selby p. Bone. 1999 May;24(5 Suppl):81S-85S. doi: 10.1016/s8756-3282(99)00071-x. Bone. 1999. PMID: 10321935 Free article. Clinical Trial. No abstract available.
National Osteoporosis Society vitamin D guideline summary.
Aspray TJ, Bowring C, Fraser W, Gittoes N, Javaid MK, Macdonald H, Patel S, Selby P, Tanna N, Francis RM; National Osteoporosis Society. Aspray TJ, et al. Among authors: selby p. Age Ageing. 2014 Sep;43(5):592-5. doi: 10.1093/ageing/afu093. Epub 2014 Jul 28. Age Ageing. 2014. PMID: 25074538
Early changes in biochemical markers of bone turnover and their relationship with bone mineral density changes after 24 months of treatment with teriparatide.
Blumsohn A, Marin F, Nickelsen T, Brixen K, Sigurdsson G, González de la Vera J, Boonen S, Liu-Léage S, Barker C, Eastell R; EUROFORS Study Group. Blumsohn A, et al. Osteoporos Int. 2011 Jun;22(6):1935-46. doi: 10.1007/s00198-010-1379-y. Epub 2010 Oct 12. Osteoporos Int. 2011. PMID: 20938767 Free PMC article. Clinical Trial.
Quality of life in men living with advanced and localised prostate cancer in the UK: a population-based study.
Downing A, Wright P, Hounsome L, Selby P, Wilding S, Watson E, Wagland R, Kind P, Donnelly DW, Butcher H, Catto JWF, Cross W, Mason M, Sharp L, Weller D, Velikova G, McCaughan E, Mottram R, Allen M, Kearney T, McSorley O, Huws DW, Brewster DH, McNair E, Gavin A, Glaser AW. Downing A, et al. Among authors: selby p. Lancet Oncol. 2019 Mar;20(3):436-447. doi: 10.1016/S1470-2045(18)30780-0. Epub 2019 Jan 31. Lancet Oncol. 2019. PMID: 30713036 Free article.
Systematic review of the use of bone turnover markers for monitoring the response to osteoporosis treatment: the secondary prevention of fractures, and primary prevention of fractures in high-risk groups.
Burch J, Rice S, Yang H, Neilson A, Stirk L, Francis R, Holloway P, Selby P, Craig D. Burch J, et al. Among authors: selby p. Health Technol Assess. 2014 Feb;18(11):1-180. doi: 10.3310/hta18110. Health Technol Assess. 2014. PMID: 24534414 Free PMC article. Review.
926 results